Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Ulcerative Colitis Treated With Mesalamine
NCT05553704Phase 2Completed
- Sponsor
- Tanta University
- Start
- Nov 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of liquid metformin (Aspargo Labs) in ulcerative colitis (UC) (2 arms), sponsored by Tanta University. Primary endpoint: Partial Mayo Score Index at 6 months. Started Nov 2022; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05553704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05553704.